Don t focus on herd immunity, vaccination should be comprehensive: COVID-19 panel expert Toggle share menu
Advertisement
Don t focus on herd immunity, vaccination should be comprehensive: COVID-19 panel expert
Associate Professor Lim Poh Lian, an infectious diseases outbreak expert, dressed in personal protective equipment. (Photo courtesy of A/Prof Lim)
28 Dec 2020 10:25AM) Share this content
Bookmark
SINGAPORE: Rather than aim for a certain percentage of the population to be inoculated to achieve COVID-19 herd immunity, Singapore should vaccinate as many people as possible.
In an interview with CNA, Associate Professor Lim Poh Lian, who is on the Expert Committee for COVID-19 Vaccination, said that it s a mistake to focus on percentages when it comes to COVID-19 vaccination.
SINGAPORE - It is not new for vaccinations to have indemnity and no-fault compensation mechanisms in place to protect both the individuals and companies, while allowing millions to have access to the vaccines.
This looks set to be applied to Covid-19 vaccines as well, with Pfizer obtaining indemnity from the British government against any incidents as countries worldwide start securing the Pfizer-BioNTech Covid-19 vaccine for their people.
Singapore Association of Pharmaceutical Industries president Ashish Pal said at a Straits Times Reset webinar, The A-Z of the Covid-19 vaccine, on Thursday (Dec 17) that this is not new for vaccines. You really want to get to a point where you have a very, very effective use of your resources - people and dollars - so that vaccines are actually administered and populations start to acquire immunity. To achieve that, you want to look at two different mechanisms in place - indemnity and no-fault compensation, he said.
7:11 PM MYT
Cargo containing pharmaceuticals, with a thermal blanket to maintain low temperatures, being loaded up a Singapore Airlines plane on Dec 5, 2020.- ST
SINGAPORE (The Straits Times/ANN): A critical part in the distribution of the temperature-sensitive Covid-19 vaccines, made by Moderna and Pfizer and BioNTech, is to ensure a specified temperature range is maintained.
In Singapore, stringent checks are in place that ensure the cold chain for these vaccines is not compromised and that the vaccines remain safe and effective, experts said on Thursday (Dec 17) during a Straits Times webinar on Covid-19 vaccination.
Their assurance comes after the Government announced on Monday its plans to roll out Covid-19 vaccines in Singapore soon, including the Moderna and Pfizer-BioNTech vaccines.
SINGAPORE - A critical part in the distribution of the temperature-sensitive Covid-19 vaccines, made by Pfizer and BioNTech as well as Moderna, is to ensure a specified temperature range is maintained.
In Singapore, stringent checks are in place that ensure the cold chain for these vaccines is not compromised and that the vaccines remain safe and effective, experts said on Thursday (Dec 17) during a Straits Times webinar on Covid-19 vaccination.
Their assurance comes after the Government announced on Monday its plans to roll out Covid-19 vaccines in Singapore soon, including the Pfizer-BioNTech vaccine which the Health Sciences Authority has approved.